Increlex – Mecasermin Injection for Severe Primary IGF‑1 Deficiency

What Is Increlex?

Increlex (mecasermin injection, 10 mg/mL) is a recombinant DNA‑derived form of human insulin‑like growth factor‑1 (IGF‑1). Manufactured by Ipsen Pharma, it is approved in the US, EU, and other regions for the treatment of growth failure in children with severe primary IGF‑1 deficiency (SPIGFD).

Unlike growth hormone therapies, Increlex directly replaces IGF‑1, the hormone responsible for stimulating bone and muscle growth.

How Increlex Works

• IGF‑1 replacement: Provides the missing growth factor in children with SPIGFD.
• Bone growth stimulation: Promotes linear growth by acting on growth plates.
• Muscle development: Enhances protein synthesis and lean body mass.
• Metabolic regulation: Improves glucose utilization and energy balance.

Indications

Increlex is indicated for:

• Children with SPIGFD: Documented low IGF‑1 levels despite normal growth hormone secretion.
• Not for use in: Children with growth hormone deficiency, malnutrition, hypothyroidism, or those receiving long‑term steroids.

Benefits

• Direct IGF‑1 therapy: Targets the root cause of growth failure.
• Proven efficacy: Clinical trials show significant improvements in height velocity.
• Trusted brand: Manufactured by Ipsen, a global leader in endocrinology.
• Global recognition: Approved by FDA, EMA, and other regulatory agencies.

Administration & Dosage

• Formulation: 10 mg/mL solution for subcutaneous injection.
• Route: Subcutaneous injection, usually twice daily.
• Timing: Administer shortly before or after a meal/snack to reduce hypoglycemia risk.
• Dosage: Individualized based on body weight and clinical response.

Safety & Precautions

• Common side effects: Hypoglycemia, headache, nausea, fatigue, tonsillar hypertrophy.
• Serious risks: Intracranial hypertension, slipped capital femoral epiphysis, and potential malignancy risk.
• Contraindications: Active or suspected cancer, closed epiphyses (finished growth), hypersensitivity to mecasermin.
• Monitoring: Requires regular follow‑up with pediatric endocrinologists.

Global Availability

Prime Equine Meds ensures secure and reliable access to Increlex across multiple regions:

• UK & Ireland – Licensed for pediatric SPIGFD.
• Canada & USA – FDA‑approved and widely prescribed.
• Australia & New Zealand – Available through specialist endocrinologists.
• Europe (Germany, France, Spain, Portugal, Switzerland, etc.) – EU‑compliant distribution with multilingual support.

Why Choose Prime Equine Meds?

• Authenticity Guaranteed: Genuine Increlex injections sourced from Ipsen.
• Worldwide Shipping: Covering major European countries, UK, Canada, and Australia.
• Expert Support: Guidance on safe handling, dosage, and administration.
• Customer Confidence: Transparent policies, secure checkout, and responsive service.

Introduction to Increlex: Unveiling a Growth Revolution:

Increlex (mecasermin) is a prescription medication that contains recombinant human insulin-like growth factor-1 (IGF-1). It is used for the treatment of a rare medical condition known as growth hormone insensitivity syndrome (GHIS), also referred to as insulin-like growth factor-1 deficiency (IGFD).

Generic Name: Mecasermin

Brand name: Increlex

GHIS is a genetic disorder characterized by a lack of response to growth hormone (GH), which leads to short stature and poor growth in affected individuals. Normally, GH is produced by the pituitary gland and stimulates the production of IGF-1 in the liver. IGF-1 plays a crucial role in promoting the growth and development of bones, muscles, and other tissues.

However, individuals with GHIS have a defect in the GH receptor or related signaling pathways, which results in reduced production of IGF-1 and impaired growth. Increlex, being a form of recombinant IGF-1, can help address this deficiency and promote linear growth in children with GHIS.

Key points about Increlex:

Indication: Increlex is indicated for the long-term treatment of children with growth failure due to severe primary IGF-1 deficiency (GHIS/IGFD) or with GH gene deletion who have developed neutralizing antibodies to GH.

Administration: Increlex is administered by subcutaneous (under the skin) injection. It is usually given once or twice daily, depending on the specific treatment plan recommended by the healthcare provider.

Monitoring: Regular monitoring of growth and IGF-1 levels is essential to adjust the dose and ensure optimal treatment outcomes.

Adverse Effects: Like any medication, Increlex can have side effects. Common side effects may include injection site reactions, headaches, and low blood sugar (hypoglycemia). Your doctor will monitor for these and other potential side effects.

Contraindications: Increlex should not be used in individuals with a known hypersensitivity to mecasermin or any of its components.

Usage in Athletes: It’s important to note that IGF-1, including Increlex, has been abused by some athletes and bodybuilders for its potential to enhance muscle growth and performance. However, such use is not approved and can lead to serious health risks.

Prime Equine Meds: Your Trusted Online Source for Increlex

Prime Equine Meds, your premier destination for purchasing Increlex online. We understand the importance of reliable and convenient access to quality medications for your pet’s health needs. Whether you’re seeking Increlex to address growth hormone deficiencies or other veterinary requirements, we’re here to ensure a seamless and secure shopping experience.

Why Choose Prime Equine Meds for Increlex?

Trusted Expertise: With years of experience in the veterinary pharmaceutical industry, we are your knowledgeable partner in animal health.

Authenticity Guaranteed: Our Increlex products are sourced directly from reputable manufacturers, ensuring authenticity and effectiveness.

Convenience at Your Fingertips: Our user-friendly online platform allows you to buy Increlex from the comfort of your home, eliminating the hassle of traditional pharmacy visits.

Increlex for sale today from Prime Equine Meds:

Elevate your pet’s well-being with Increlex from Prime Equine Meds. Browse our selection, place your order, and rest assured that you’re providing the best care for your furry companion’s health and growth needs.

Please note that Increlex is a prescription medication, and you should consult a qualified veterinarian before administering it to your pet. Prime Equine Meds encourages responsible and informed pet healthcare decisions.

Increlex is a specialized IGF‑1 therapy for children with severe primary IGF‑1 deficiency. By directly replacing the missing growth factor, it helps restore normal growth and development. With its proven efficacy, global availability, and trusted manufacturing, Increlex remains a cornerstone of pediatric endocrinology. Prime Equine Meds is committed to providing safe, authentic, and accessible Increlex worldwide, ensuring families and healthcare providers have reliable solutions for growth failure.